Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors

被引:24
|
作者
Chi, Weiwei [1 ]
Warner, Richard R. P. [2 ]
Chan, David L. [3 ]
Singh, Simron [4 ]
Segelov, Eva [5 ,6 ]
Strosberg, Jonathan [7 ]
Wisnivesky, Juan [1 ]
Kim, Michelle K. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
[3] Sunnybrook Hlth Sci Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Odette Canc Res Program, Toronto, ON, Canada
[5] Monash Univ, Dept Oncol, Melbourne, Vic, Australia
[6] Monash Hlth, Melbourne, Vic, Australia
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept GI Oncol, Tampa, FL USA
关键词
neuroendocrine tumor; gastrointestinal tract; pancreas; ENETS CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; SINGLE INSTITUTION; GRADING SYSTEM; NEOPLASMS; MANAGEMENT; UPDATE; SURVIVAL; EPIDEMIOLOGY;
D O I
10.1097/MPA.0000000000001005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare but have been increasing in incidence. Limited data on the long-term outcomes of patients with these tumors are available. Methods In this study, we used population-based data from the National Cancer Institute to assess long-term disease-specific survival (DSS) of patients who have undergone surgery for nonmetastatic disease. All patients with NETs of the stomach, small intestine, colon, rectum, appendix, and pancreas diagnosed between 1988 and 2009 were identified from the Surveillance, Epidemiology and End Results registry. Staging was derived from Surveillance, Epidemiology and End Results data using the European Neuroendocrine Tumor Society guidelines. Cases with incomplete staging data were excluded, along with those with stage IV disease, or those who did not undergo surgical resection. Results Kaplan-Meier analyses were constructed to determine DSS. Analyses were further stratified according to tumor site, stage at diagnosis, and tumor grade. Overall, 13,348 patients with GEP-NETs meeting the inclusion criteria were identified. Conclusions There were excellent outcomes for most GEP-NET patients, with a 20-year DSS of greater than 75% across all sites and stages. Pancreatic tumors had the worst outcomes, but DSS remains greater than 50% at 20 years.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [1] Long-Term Outcomes after Liver Transplantation with Curative Intent for Gastroenteropancreatic Neuroendocrine Tumors
    Goh, Brian K.
    Burns, Justin M.
    Sanchez, William
    Heimbach, Julie K.
    Hobday, Timothy J.
    Gores, Gregory J.
    Rosen, Charles B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 75 - 75
  • [2] Long-Term Outcomes after Liver Transplantation with Curative Intent for Gastroenteropancreatic Neuroendocrine Tumors
    Goh, B. K.
    Burns, J. M.
    Sanchez, W.
    Heimbach, J. K.
    Hobday, T. J.
    Gores, G. J.
    Rosen, C. B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 63 - 64
  • [3] Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors
    Kiesewetter, Barbara
    Pflueger, Friedrich Franz
    Melhorn, Philipp
    Mazal, Peter
    Raderer, Markus
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [4] Impact of surgical approach on short- and long-term outcomes in gastroenteropancreatic neuroendocrine carcinomas
    Chen, Qichen
    Rhodin, Kristen E.
    Li, Kan
    Kanu, Elishama
    Zani, Sabino
    Lidsky, Michael E.
    Zhao, Jianjun
    Wei, Qingyi
    Luo, Sheng
    Zhao, Hong
    [J]. HPB, 2023, 25 (10) : 1255 - 1267
  • [5] Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors
    Kiyoun Yi
    Gwang Ha Kim
    Su Jin Kim
    Cheol Woong Choi
    Moon Won Lee
    Bong Eun Lee
    Geun Am Song
    [J]. Scientific Reports, 13
  • [6] Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors
    Yi, Kiyoun
    Kim, Gwang Ha
    Kim, Su Jin
    Choi, Cheol Woong
    Lee, Moon Won
    Lee, Bong Eun
    Song, Geun Am
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Impact of surgical approach on short- and long-term outcomes in gastroenteropancreatic neuroendocrine carcinomas
    Chen, Q.
    Rhodin, K. E.
    Li, K.
    Kanu, E.
    Zani, S.
    Lidsky, M. E.
    Zhao, J.
    Wei, Q.
    Luo, S.
    Zhao, H.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 70 - 70
  • [8] Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors
    Xiang, Jun-Xi
    Nan, Yang-Long
    He, Jin
    Lopez-Aguiar, Alexandra G.
    Poultsides, George
    Rocha, Flavio
    Weber, Sharon
    Fields, Ryan
    Idrees, Kamran
    Cho, Cliff
    Maithel, Shishir K.
    Lv, Yi
    Zhang, Xu-Feng
    Pawlik, Timothy M.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (06) : 852 - 859
  • [9] Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
    Pape, Ulrich-Frank
    Berndt, Uta
    Muller-Nordhorn, Jacqueline
    Bohmig, Michael
    Roll, Stephanie
    Koch, Martin
    Willich, Stefan N.
    Wiedenmann, Bertram
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 1083 - 1097
  • [10] Long-Term Outcomes Following Endoscopic Resection of Rectal Neuroendocrine Tumors
    Ego, Mai
    Ishii, Naoki
    Nakano, Kaoru
    Taketa, Takashi
    Suzuki, Koyu
    Okamoto, Takeshi
    Shimamura, Yuto
    Ikeya, Takashi
    Nakamura, Kenji
    Takagi, Koichi
    Fukuda, Katsuyuki
    Fujita, Yoshiyuki
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S668 - S668